Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics of BDHK-2009 Tablets in Healthy Adult Participants: a Randomized, Double-blind, Placebo-controlled, Single-dose/Multiple-dose Escalation Study.

NCT07632573 is registered in ClinicalTrials.gov with Benethera (Shaoxing) Biotechnology Co., Ltd. as lead sponsor.

NCT NCT07632573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07632573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics/Pharmacodynamics of BDHK-2009 Tablets in Healthy Adult Participants: a Randomized, Double-blind, Placebo-controlled, Single-dose/Multiple-dose Escalation Study.
Lead sponsor
Benethera (Shaoxing) Biotechnology Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
May 18, 2026
Completion date
February 28, 2027
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cd - crohn's disease, ibd (inflammatory bowel disease), ulcerative colitis (disorder), ulcerative colitis (uc), ulcerative colitis acute